Last update 21 Nov 2024
Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Recombinant protein |
Synonyms- |
Target |
Mechanism Lysostaphin stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)评价重组溶葡萄球菌酶涂剂治疗深Ⅱo烧伤创面合并耐甲氧西林金黄色葡萄球菌MRSA感染的有效性和安全性的多中心、随机、盲法评估、阳性药对照IIIb期临床预试验
[Translation] A multicenter, randomized, blinded, active-controlled phase IIIb clinical pilot trial to evaluate the efficacy and safety of recombinant lysostaphin paint in the treatment of deep IIo burn wounds complicated with methicillin-resistant Staphylococcus aureus (MRSA) infection
外用重组溶葡萄球菌酶治疗深Ⅱo烧伤创面合并MRSA感染的疗效和安全性的多中心随机双盲Ⅲ期临床试验
[Translation] A multicenter, randomized, double-blind, phase III clinical trial on the efficacy and safety of topical recombinant lysostaphin in the treatment of deep Ⅱo burn wounds complicated with MRSA infection
外用重组溶葡萄球菌酶治疗深Ⅱo烧伤创面合并耐甲氧西林金黄色葡萄球菌(MRSA)感染的有效性和安全性Ⅱ期临床试验
[Translation] Phase II clinical trial on the efficacy and safety of topical recombinant lysostaphin in the treatment of deep Ⅱo burn wounds complicated with methicillin-resistant Staphylococcus aureus (MRSA) infection
100 Clinical Results associated with Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)
Login to view more data
100 Translational Medicine associated with Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)
Login to view more data
100 Patents (Medical) associated with Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)
Login to view more data
100 Deals associated with Recombinant lysostaphin(Shanghai High-Tech United Biological Technology Research Development Co Ltd)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Burns | Phase 3 | CN | 23 Feb 2011 | |
| MRSA - Methicillin resistant Staphylococcus aureus infection | Phase 3 | CN | 23 Feb 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free